Cargando…

Prevention of cisplatin‐induced hearing loss in children: Informing the design of future clinical trials

Cisplatin is an essential chemotherapeutic agent in the treatment of many pediatric cancers. Unfortunately, cisplatin‐induced hearing loss (CIHL) is a common, clinically significant side effect with life‐long ramifications, particularly for young children. ACCL05C1 and ACCL0431 are two recently comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minasian, Lori M., Frazier, A. Lindsay, Sung, Lillian, O’Mara, Ann, Kelaghan, Joseph, Chang, Kay W., Krailo, Mark, Pollock, Brad H., Reaman, Gregory, Freyer, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051159/ https://www.ncbi.nlm.nih.gov/pubmed/29846043 http://dx.doi.org/10.1002/cam4.1563

Ejemplares similares

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era
por: Roth, Michael E., et al.
Publicado: (2020)

Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE(®) to Provide Two Distinct and Complementary Perspectives
por: Minasian, Lori M, et al.
Publicado: (2022)

Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin
por: Chirtes, Felician, et al.
Publicado: (2014)

Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
por: Sheth, Sandeep, et al.
Publicado: (2019)

Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
por: Lee, Chang Ho, et al.
Publicado: (2020)

Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo
por: Nan, Benyu, et al.
Publicado: (2022)

Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss: Miniperspective
por: Hazlitt, Robert A., et al.
Publicado: (2018)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019)

Exosomes function as nanoparticles to transfer miR-199a-3p to reverse chemoresistance to cisplatin in hepatocellular carcinoma
por: Zhang, Kun, et al.
Publicado: (2020)

CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss
por: Teitz, Tal, et al.
Publicado: (2018)

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss
por: Ramaswamy, Bharath, et al.
Publicado: (2017)

Absence of Relationship between Mitochondrial DNA Haplogroups and Cisplatin-Induced Hearing Loss
por: Graterol, D., et al.
Publicado: (2017)

Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021)

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
por: Zhang, Xindi, et al.
Publicado: (2022)

Predicting Hearing Loss in Testicular Cancer Patients after Cisplatin-Based Chemotherapy
por: Garcia, Sara L., et al.
Publicado: (2023)

BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma
por: Gao, Wei, et al.
Publicado: (2017)

Hearing Loss in Mucopolysaccharidoses: Current Knowledge and Future Directions
por: Wolfberg, Jeremy, et al.
Publicado: (2020)

Future directions for screening and treatment in congenital hearing loss
por: Thorpe, Ryan K, et al.
Publicado: (2020)

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway
por: Yang, Ying, et al.
Publicado: (2021)

FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
por: Xiong, Xifeng, et al.
Publicado: (2022)

Maternal COVID-19 and neonatal hearing loss: a multicentric survey
por: Mostafa, Badr Eldin, et al.
Publicado: (2021)

The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
por: Ghosh, Sumana, et al.
Publicado: (2018)

Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches
por: Moxon‐Emre, Iska, et al.
Publicado: (2021)

Recent advances and future challenges in gene therapy for hearing loss
por: Amariutei, Ana E., et al.
Publicado: (2023)

Targeting phosphodiesterase 3B enhances cisplatin sensitivity in human cancer cells
por: Uzawa, Katsuhiro, et al.
Publicado: (2013)

Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
por: Hastings, Jordan F, et al.
Publicado: (2020)

Hearing aid effectiveness on patients with chronic tinnitus and associated hearing loss()
por: Simonetti, Patricia, et al.
Publicado: (2022)

The decline in stomach cancer mortality: exploration of future trends in seven European countries
por: Amiri, Masoud, et al.
Publicado: (2010)

Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives
por: Wagstaff, Megan, et al.
Publicado: (2022)

Family history of cancer in children and adolescents with germ cell tumours: a report from the Children’s Oncology Group
por: Poynter, Jenny N, et al.
Publicado: (2018)

Trajectory of hearing loss in children with unilateral hearing loss
por: Fitzpatrick, Elizabeth M., et al.
Publicado: (2023)

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children
por: Pussegoda, K, et al.
Publicado: (2013)

Profound sensorineural hearing loss after one cycle of intraperitoneal cisplatin in treatment of advanced ovarian cancer
por: McDonald, Megan E., et al.
Publicado: (2017)

The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model
por: Wertman, Jaime N, et al.
Publicado: (2020)

Four Cycles of Etoposide plus Cisplatin for Patients with Good‐Risk Advanced Germ Cell Tumors
por: Funt, Samuel A., et al.
Publicado: (2021)

Health Status of Adults with Hearing Loss in the United States
por: Glassman, Jennifer, et al.
Publicado: (2021)

Hearing Assessment of Neonates at Risk for Hearing Loss at a Hearing Health High Complexity Service: An Electrophysiological Assessment
por: Reis, Flavia Mara Fernandes da Silva, et al.
Publicado: (2019)

Hearing loss at work? Hearing loss from leisure activities?
Publicado: (2006)

Vitamin D(3) enhances the response to cisplatin in bladder cancer through VDR and TAp73 signaling crosstalk
por: Bunch, Brittany L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_haulm2h23pqtdaaos48m1h9jo6